News from samsung biologics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 26, 2021, 19:26 ET Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA

Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin...

Jan 26, 2021, 02:00 ET Samsung Biologics Reports 66% Increase in 2020 Revenue Achieving "1 Trillion Won" Target Sales

Samsung Biologics (KRX: 207940.KS) reported its fourth quarter and full-year 2020 financial results indicating strong business performance,...

Jan 13, 2021, 10:17 ET Samsung Biologics Shares 'Vision' for Next Decade at the 39th Annual JP Morgan Healthcare Conference

Samsung Biologics (207940.KS) set forth its dynamic growth plan for the next decade at the 2021 Annual JP Morgan Healthcare Conference. John Rim,...

Dec 16, 2020, 07:00 ET Samsung Biologics Names John Rim as President and CEO

Samsung Biologics (KRX: 207940.KS) announced John Rim as its President and CEO. The appointment was made effective immediately and formalized via the ...

Dec 04, 2020, 07:00 ET Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch

Samsung Biologics (KRX: 207940.KS) announced the launch of a virtual showroom to provide key features and real-time construction updates of its...

Nov 18, 2020, 07:00 ET Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility

Samsung Biologics (KRX: 207940.KS) officially began construction of its Plant 4 in Incheon, South Korea. Dubbed the "Super Plant," the new,...

Nov 17, 2020, 07:00 ET Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments

Samsung Biologics' partnership with Eli Lilly and Company is expected to greatly accelerate the global supply for Lilly's COVID-19 antibody therapies ...

Nov 04, 2020, 07:00 ET Samsung Biologics' Virtual Exhibition Hall earns top industry award for digital creativity and innovation

Samsung Biologics' Virtual Exhibition Hall was recently recognized for its highly interactive digital capabilities and virtual reality (VR)...

Nov 02, 2020, 07:00 ET Samsung Biologics and Checkpoint Therapeutics Expand Manufacturing Partnership for Cosibelimab

Samsung Biologics Co., Ltd. ("Samsung Biologics") (KRX: 207940.KS) and Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), today announced...

Nov 01, 2020, 19:27 ET Samsung Biologics Establishes Partnership with China Biotech GeneQuantum Healthcare to Collaborate on ADC Development

Samsung Biologics (207940.KS) has entered into a strategic partnership with GeneQuantum Healthcare, a China biotech company, to jointly develop an...

Oct 28, 2020, 20:38 ET Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center

At a virtual ceremony today, Samsung Biologics (KRX: 207940.KS) announced the grand opening of its first US CDO R&D Center in San Francisco, bringing ...

Oct 21, 2020, 07:00 ET Samsung Biologics' strategic business operations continue to support strong third quarter earnings

Samsung Biologics (KRX: 207940.KS) maintained steady financial results for its fiscal 2020 third quarter ending September 30, demonstrating confident ...

Oct 20, 2020, 07:00 ET Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment

Samsung Biologics (207940.KS) has entered into a partnership agreement with biotech Dinona, further expanding its CDO capabilities to provide a full...

Oct 19, 2020, 07:00 ET Samsung Biologics partners with BioEleven for cancer immunotherapy development and manufacturing

Samsung Biologics (207940.KS) has entered into a partnership agreement with BioEleven to develop and manufacture BN-101A, a third-generation...

Sep 23, 2020, 20:00 ET Samsung Biologics signs strategic partnership with Kanaph Therapeutics to develop treatment for retinal diseases

Samsung Biologics (207940.KS) and Kanaph Therapeutics have entered into a strategic partnership to develop KNP-301, a bi-specific Fc fusion protein...

Sep 21, 2020, 19:00 ET Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply

Samsung Biologics (207940.KS) and AstraZeneca announced a long-term supply agreement, valued at approximately $330.8 million. Under this agreement,...

Sep 16, 2020, 20:43 ET Samsung Biologics signs development agreement with Panolos for solid tumor treatment

Samsung Biologics (207940.KS) has entered into a service agreement with Panolos Bioscience to develop PB101, an Fc-fusion protein intended to treat...

Aug 10, 2020, 20:30 ET Samsung Biologics to add fourth plant with growing demand

Samsung Biologics (KRX: 207940.KS) today held an online press conference to announce its plans to break ground for a fourth plant within this year....

Aug 04, 2020, 21:09 ET Samsung Biologics launches S-CHOice cell line expression technology

Samsung Biologics (KRX: 207940.KS) today held an online ceremony to announce the launch of its proprietary cell line technology, S-CHOice. S-CHOice...

Jul 21, 2020, 08:20 ET Samsung Biologics Posts Strong Second Quarter Earnings With 48.5% Increase In Sales

Samsung Biologics (KRX: 207940.KS) announced today strong financial results for its fiscal 2020 second quarter ending June 30, 2020, maintaining...

Jul 20, 2020, 22:13 ET Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon

Samsung Biologics (207940.KS) announced a plan to expand its Drug Product (DP) capability in line with increasing market demand and to ensure...

Jul 15, 2020, 01:46 ET Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

Samsung Biologics (207940.KS) and ImmuneOncia Therapeutics held a signing ceremony today for a contract to develop and manufacture five candidate...

Jul 11, 2020, 20:00 ET Samsung Biologics signs additional development and manufacturing agreement with STCube

Samsung Biologics (207940.KS) has further expanded its partnership with STCube through an additional development and manufacturing service agreement...

Jun 08, 2020, 07:00 ET Samsung Biologics Unveils Virtual Exhibition Hall to Digitally Connect with Clients at BIO 2020

Samsung Biologics (207940.KS) announced the launch of a Virtual Exhibition Hall, coinciding with the opening of BIO Digital 2020 week. As the...

May 21, 2020, 19:11 ET GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio

GlaxoSmithKline plc (LSE/NYSE: GSK) and Samsung Biologics (207940.KS) have entered into a partnership to provide GSK with additional capacity to...